Abstract:Liquisolid systems are an innovative dosage form used for enhancing dissolution rate and improving in vivo bioavailability of poorly soluble drugs. These formulations require specific evaluation methods for their quality assurance (e.g., evaluation of angle of slide, contact angle, or water absorption ratio). The presented study is focused on the preparation, modern in vitro testing, and evaluation of differences of liquisolid systems containing varying amounts of a drug in liquid state (polyethylene glycol 40… Show more
“…26 . These results confirmed conclusions of the previous study 22 , where was observed that preparation of liquisolid systems by spraying in the fluid bed equipment led to more uniform tablets in comparison to the simple blending method.…”
Section: Drug Contentsupporting
confidence: 92%
“…However, liquisolid system with acceptable flowing and compressible properties can be prepared only if a maximum liquid load of the carrier material is not exceeded 30 . Therefore, according to the previous study 22 , value of liquid load factor (L f ) (the weight ratio between the drug in liquid state and the carrier material) was established to 0.6 and excipient ratio (R) (the weight ratio between the carrier and the coating material) to 50 in all formulations.…”
Section: Resultsmentioning
confidence: 99%
“…The solution was sprayed onto a calculated amount of carrier Neusilin Õ US2 (magnesium aluminometasilicate) and coated with Aerosil Õ 200 (colloidal silica) to obtain a dry powder with sufficient flow properties for further processing. According to the previous study 22 , the value of liquid load factor (Lf) (the weight ratio between the drug in liquid state and the carrier material) was established to 0.6 and excipient ratio (R) (the weight ratio between the carrier and the coating material) to 50 in all formulations. The drug solution was sprayed onto Neusilin Õ US2, and the mixture was then passed through a sieve (mesh size 1 mm) and mixed in a homogenizer for 10 min with the aim to ensure homogenous distribution of the drug in liquid state throughout the whole amount of carrier material.…”
Section: Preparation Of Liquisolid Powders and Formulation Of Tabletsmentioning
confidence: 99%
“…Its values ranged between 3.57 ± 0.13 s/100 g (K 3.5%) and 7.72 ± 0.26 s/100 g (E 2.5%). The relatively low values of flowability correspond to increased weight of Neusilin Õ US2 particles, which pores were filled with rosuvastatin solution 22 . It was proved by Gumaste et al 31 that the majority of the liquid is adsorbed into mesopores and deep into the channels of the Neusilin Õ US2's macropores.…”
Section: Powder Flow Of the Liquisolid Tableting Mixturesmentioning
confidence: 99%
“…The results of the uniformity of mass evaluation (Table 3) showed that preparation of liquisolid system by spraying in fluid bed equipment led to the formulation of powder mixtures with good flow properties and compressibility and to tablets with homogeneous weight 22 . None of the prepared liquisolid tablets deviated from the average value by more than 5% and hence met the requirement given by Ph.…”
“…26 . These results confirmed conclusions of the previous study 22 , where was observed that preparation of liquisolid systems by spraying in the fluid bed equipment led to more uniform tablets in comparison to the simple blending method.…”
Section: Drug Contentsupporting
confidence: 92%
“…However, liquisolid system with acceptable flowing and compressible properties can be prepared only if a maximum liquid load of the carrier material is not exceeded 30 . Therefore, according to the previous study 22 , value of liquid load factor (L f ) (the weight ratio between the drug in liquid state and the carrier material) was established to 0.6 and excipient ratio (R) (the weight ratio between the carrier and the coating material) to 50 in all formulations.…”
Section: Resultsmentioning
confidence: 99%
“…The solution was sprayed onto a calculated amount of carrier Neusilin Õ US2 (magnesium aluminometasilicate) and coated with Aerosil Õ 200 (colloidal silica) to obtain a dry powder with sufficient flow properties for further processing. According to the previous study 22 , the value of liquid load factor (Lf) (the weight ratio between the drug in liquid state and the carrier material) was established to 0.6 and excipient ratio (R) (the weight ratio between the carrier and the coating material) to 50 in all formulations. The drug solution was sprayed onto Neusilin Õ US2, and the mixture was then passed through a sieve (mesh size 1 mm) and mixed in a homogenizer for 10 min with the aim to ensure homogenous distribution of the drug in liquid state throughout the whole amount of carrier material.…”
Section: Preparation Of Liquisolid Powders and Formulation Of Tabletsmentioning
confidence: 99%
“…Its values ranged between 3.57 ± 0.13 s/100 g (K 3.5%) and 7.72 ± 0.26 s/100 g (E 2.5%). The relatively low values of flowability correspond to increased weight of Neusilin Õ US2 particles, which pores were filled with rosuvastatin solution 22 . It was proved by Gumaste et al 31 that the majority of the liquid is adsorbed into mesopores and deep into the channels of the Neusilin Õ US2's macropores.…”
Section: Powder Flow Of the Liquisolid Tableting Mixturesmentioning
confidence: 99%
“…The results of the uniformity of mass evaluation (Table 3) showed that preparation of liquisolid system by spraying in fluid bed equipment led to the formulation of powder mixtures with good flow properties and compressibility and to tablets with homogeneous weight 22 . None of the prepared liquisolid tablets deviated from the average value by more than 5% and hence met the requirement given by Ph.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.